Efficacy and safety of infliximab therapy in plaque psoriasis patients previously treated with etanercept: Analysis of PSUNRISE

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2009.11.511 ◽

2010 ◽

Vol 62 (3) ◽

pp. AB133 ◽

Keyword(s):

Plaque Psoriasis ◽

Infliximab Therapy ◽

Efficacy And Safety ◽

Previously Treated

Download Full-text

Importance of trough levels and antibody titers on the efficacy and safety of Infliximab therapy in inflammatory bowel disease

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1312407 ◽

2012 ◽

Vol 50 (05) ◽

Author(s):

T Molnár ◽

K Farkas ◽

É Pallagi ◽

R Gyulai ◽

R Kui ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Infliximab Therapy ◽

Efficacy And Safety ◽

Antibody Titers ◽

Inflammatory Bowel ◽

Download Full-text

The efficacy and safety of LY2963016 among patients with Type 1 and Type 2 diabetes previously treated with insulin glargine

Diabetologie und Stoffwechsel ◽

10.1055/s-0035-1549538 ◽

2015 ◽

Vol 10 (S 01) ◽

Author(s):

D Dahl ◽

LB Lacaya ◽

RK Pollom ◽

LL Ilag ◽

JS Zielonka

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Efficacy And Safety ◽

Previously Treated

Download Full-text

Efficacy and safety of Boceprevir triple therapy in previously treated patients with HCV Genotype 1 (G1) infection in German real-life

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1567991 ◽

2015 ◽

Vol 53 (12) ◽

Author(s):

P Buggisch ◽

H Löhr ◽

G Teuber ◽

H Steffens ◽

M Kraus ◽

...

Keyword(s):

Triple Therapy ◽

Real Life ◽

Efficacy And Safety ◽

Hcv Genotype ◽

Previously Treated Patients ◽

Previously Treated ◽

Download Full-text

Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.15 ◽

2019 ◽

Vol 3 ◽

pp. S15

Author(s):

Mark Lebwohl ◽

James Del Rosso ◽

Chih-ho Hong ◽

Anna M Tallman ◽

Leon Kircik

Keyword(s):

Plaque Psoriasis ◽

Randomized Study ◽

Skin Type ◽

Efficacy And Safety ◽

Disease Characteristics

Abstract not available.

Download Full-text

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

Case Medical Research ◽

10.31525/ct1-nct03927352 ◽

2019 ◽

Author(s):

Keyword(s):

Plaque Psoriasis ◽

Research Study ◽

Efficacy And Safety

Download Full-text

Faculty Opinions recommendation of An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718028323.793480222 ◽

2013 ◽

Author(s):

Richard Riedel

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 2 Study ◽

Open Label Phase ◽

Metastatic Soft Tissue Sarcoma ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727373020.793562618 ◽

2019 ◽

Author(s):

Corrado Girmenia

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Efficacy And Safety ◽

Phase 3 ◽

Previously Treated

Download Full-text

AN OPEN-LABELLED RANDOMISED COMPARATIVE EVALUATION OF THERAPEUTIC EFFICACY AND SAFETY OF APREMILAST VERSUS METHOTREXATE IN THE TREATMENT OF PATIENTS WITH CHRONIC PLAQUE PSORIASIS

10.36295/asro.2020.231517 ◽

2020 ◽

Vol 23 (15) ◽

Author(s):

Rathipriyadharshini R ◽

Prem Kumar M ◽

Soundarya S ◽

Srinivasan M.S

Keyword(s):

Plaque Psoriasis ◽

Therapeutic Efficacy ◽

Comparative Evaluation ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis

Download Full-text

Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis

Journal of Drugs in Dermatology ◽

10.36849/jdd.2020.5020 ◽

2020 ◽

Vol 19 (9) ◽

pp. 874-880

Author(s):

Leon Kircik ◽

Todd Schlesinger ◽

Emil Tanghetti

Keyword(s):

Plaque Psoriasis ◽

Betamethasone Dipropionate ◽

Efficacy And Safety

Download Full-text